MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting Litecoin creator Charlie Lee onto its board. That decision comes via a ...

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging with institutional interest and ...

This strategic move, developed in partnership with GSR and with guidance provided by Litecoin Creator and MEI Board member Charlie Lee, marks the beginning of MEI’s broader institutional treasury ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

NASDAQ-listed MEI Pharma announces a dedicated $100 million Litecoin treasury. LTC offers signs of extending the bullish leg reinforced by a robust technical structure and a MACD buy signal.

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

MEI Pharma announced a $100 million private placement to accumulate Litecoin, as well as the addition of Charlie Lee to its board. The timing comes as Bitcoin hovers around an all-time high and ...

GSR, crypto’s capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ ... MEI represents a significant step toward institutionalizing Litecoin as ...

MEI Pharma launched a $100 million Litecoin treasury strategy with backing from GSR, Titan Partners, and the Litecoin Foundation. Litecoin creator Charlie Lee joined MEI’s board, marking a rare ...